Immunodeficiency Disease
📧 Sign up to get email alerts when something new happens for Immunodeficiency Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
This clinical trial update describes a screening protocol from NIAID to identify genetic diseases of lymphocyte homeostasis and programmed c…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10) [Phase 3]
A Phase 3 clinical trial update evaluating the pharmacokinetics, efficacy, and safety of 10% intravenous immunoglobulin in pediatric patient…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures [Phase 2]
Phase 2 clinical trial update on regenerative medicine to restore hematopoiesis and immune function in immunodeficiencies and inherited bone…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants [Phase 3]
Phase 3 long-term safety study of TAK-771 in Japanese participants with primary immunodeficiency disease has completed, providing safety dat…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies [Phase 2]
Phase 2 clinical trial update on a stem cell therapy using Alpha/Beta T and CD19+ depleted peripheral stem cells for primary immunodeficienc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill
A Takeda-sponsored clinical trial evaluating at-home subcutaneous immunoglobulin replacement therapy delivered via an Alexa Skill has comple…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease [Phase 3]
An extension Phase 3 study of TAK-664 in Japanese patients with primary immunodeficiency disease has completed, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG [Phase 3]
A Phase 3 clinical trial update for Shu Yang IVIG evaluating efficacy, safety, and pharmacokinetics in primary immunodeficiency disease.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Efficacy and Safety and Pharmacokinetics of Boya IVIG [Phase 3]
A Phase 3 clinical trial update on Boya IVIG evaluating efficacy, safety, and pharmacokinetics for primary immunodeficiency disease.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID [Phase 3]
Phase 3 trial evaluating BT595 for primary immunodeficiency disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD) [Phase 4]
Phase 4 open-label study assessing pharmacokinetics, efficacy, and safety of ASCENIV IGIV in pediatric patients with primary immunodeficienc…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients [Phase 3]
Phase 3 trial assessing pharmacokinetics, efficacy, and safety of 10% intravenous immunoglobulin in patients with primary immunodeficiency d…
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL [Phase 3]
A Phase 3 study evaluating subcutaneous octanorm in primary immunodeficiency diseases has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases [Phase 3]
Phase 3 trial evaluating Octanorm for primary immunodeficiency diseases has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment [Phase 4]
Phase 4 trial assessing safety, tolerability, patient satisfaction, and cost of 16.5% subcutaneous immunoglobulin (Cutaquig) for primary and…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: CD34+ Stem Cell Infusion to Augment Graft Function [Phase 2]
Phase 2 trial investigating CD34+ stem cell infusion to augment graft function; the study was terminated with results posted in 2019.
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Immunological Characteristics of Patients With PID and IBD
This clinical trial update reports on the immunological characteristics of patients with primary immunodeficiency disorder and inflammatory …
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) [Phase 3]
Phase 3 trial evaluating a high infusion rate of NewGam 10% intravenous immunoglobulin in patients with primary immunodeficiency disease. Th…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects [Phase 4]
Phase 4 safety and efficacy study of Flebogamma 5% DIF IGIV in pediatric patients with primary immunodeficiency disease; results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) [Phase 3]
Phase 3 study evaluating pharmacokinetics, efficacy, and safety of RI-002 intravenous immunoglobulin in subjects with primary immunodeficien…
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland
This entry describes the development of an online clinical and laboratory database for primary immunodeficiencies in Switzerland, sponsored …
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients [Phase 3]
A Phase 3 trial assessing rapid infusion of intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency has completed.